EA200301134A1 - Применение дезоксипеганина для лечения патологических проявлений центральной нервной системы, вызванных интоксикацией психотропными веществами - Google Patents
Применение дезоксипеганина для лечения патологических проявлений центральной нервной системы, вызванных интоксикацией психотропными веществамиInfo
- Publication number
- EA200301134A1 EA200301134A1 EA200301134A EA200301134A EA200301134A1 EA 200301134 A1 EA200301134 A1 EA 200301134A1 EA 200301134 A EA200301134 A EA 200301134A EA 200301134 A EA200301134 A EA 200301134A EA 200301134 A1 EA200301134 A1 EA 200301134A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- substances
- disorders
- psychotropic
- treatment
- nervous system
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Addiction (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Изобретение относится к применению дезоксипеганина в виде свободной щелочи или кислой соли для лечения симптомов мозговых расстройств, расстройств центральной нервной системы или психиатрических расстройств, проявлений функциональных расстройств или расстройств, происходящих в результате возникающих при приеме психотропных веществ как последствие нерегулярного или хронического злоупотребления вызывающими привыкание веществами, опьяняющими веществами или лекарственными средствами или в качестве побочных эффектов применения, в особенности многократного или длительного применения, лекарственных средств по назначению, или в качестве эффекта применения, в особенности многократного или длительного применения, лекарственных средств не по назначению, или в результате острого отравления ядовитыми психотропными веществами, или в результате хронического воздействия токсичных веществ, обладающих психотропным действием.Отчет о международном поиске был опубликован 2003.02.27.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10119863A DE10119863A1 (de) | 2001-04-24 | 2001-04-24 | Verwendung von Desoxypeganin zur Behandlung von psychiatrischen oder zerebralen Krankheitserscheinungen |
| PCT/EP2002/004278 WO2002087553A2 (de) | 2001-04-24 | 2002-04-18 | Verwendung von desoxypeganin zur behandlung von krankheitserscheinungen des zentralen nervensystems aufgrund von intoxikationen mit psychotropen substanzen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EA200301134A1 true EA200301134A1 (ru) | 2004-04-29 |
Family
ID=7682410
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA200301134A EA200301134A1 (ru) | 2001-04-24 | 2002-04-18 | Применение дезоксипеганина для лечения патологических проявлений центральной нервной системы, вызванных интоксикацией психотропными веществами |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US20040132751A1 (ru) |
| EP (1) | EP1383503B1 (ru) |
| JP (1) | JP2004526791A (ru) |
| KR (1) | KR20030094365A (ru) |
| CN (1) | CN1638774A (ru) |
| AR (1) | AR033469A1 (ru) |
| AT (1) | ATE411024T1 (ru) |
| AU (1) | AU2002325209B2 (ru) |
| BR (1) | BR0209125A (ru) |
| CA (1) | CA2445132C (ru) |
| CZ (1) | CZ20032788A3 (ru) |
| DE (2) | DE10119863A1 (ru) |
| DK (1) | DK1383503T3 (ru) |
| EA (1) | EA200301134A1 (ru) |
| ES (1) | ES2316595T3 (ru) |
| HK (1) | HK1062402A1 (ru) |
| HU (1) | HUP0303921A3 (ru) |
| IL (1) | IL158383A0 (ru) |
| MX (1) | MXPA03009766A (ru) |
| MY (1) | MY135676A (ru) |
| NO (1) | NO20034741D0 (ru) |
| NZ (1) | NZ529005A (ru) |
| PL (1) | PL366845A1 (ru) |
| PT (1) | PT1383503E (ru) |
| SI (1) | SI1383503T1 (ru) |
| SK (1) | SK287214B6 (ru) |
| WO (1) | WO2002087553A2 (ru) |
| ZA (1) | ZA200308042B (ru) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10354894A1 (de) * | 2003-11-24 | 2005-07-07 | Hf Arzneimittelforschung Gmbh | Orale Formulierungen des Desoxypeganins und deren Anwendungen |
| DE10354893B4 (de) * | 2003-11-24 | 2011-03-10 | Hf Arzneimittelforschung Gmbh | Verwendung von Desoxypeganin zur Behandlung schizophrener Psychosen |
| ES2360547B1 (es) * | 2009-11-02 | 2012-07-04 | Consejo Superior De Investigaciones Científicas (Csic) | Procedimiento de obtención de los alcaloides activos de la planta medicinal peganum harmala y su uso. |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3797494A (en) * | 1969-04-01 | 1974-03-19 | Alza Corp | Bandage for the administration of drug by controlled metering through microporous materials |
| US3996934A (en) * | 1971-08-09 | 1976-12-14 | Alza Corporation | Medical bandage |
| US3742951A (en) * | 1971-08-09 | 1973-07-03 | Alza Corp | Bandage for controlled release of vasodilators |
| US4031894A (en) * | 1975-12-08 | 1977-06-28 | Alza Corporation | Bandage for transdermally administering scopolamine to prevent nausea |
| DE3315272C2 (de) * | 1983-04-27 | 1986-03-27 | Lohmann Gmbh & Co Kg, 5450 Neuwied | Pharmazeutisches Produkt und Verfahren zu seiner Herstellung |
| DE3843239C1 (ru) * | 1988-12-22 | 1990-02-22 | Lohmann Therapie Syst Lts | |
| US5602184A (en) * | 1993-03-03 | 1997-02-11 | The United States Of America As Represented By Department Of Health And Human Services | Monoterpenes, sesquiterpenes and diterpenes as cancer therapy |
| DE19906978B4 (de) * | 1999-02-19 | 2004-07-08 | Lts Lohmann Therapie-Systeme Ag | Pharmazeutische Zusammensetzung enthaltend Desoxypeganin zur Behandlung der Drogenabhängigkeit |
| DE19906975B4 (de) * | 1999-02-19 | 2004-04-15 | Lts Lohmann Therapie-Systeme Ag | Arzneiform zur Behandlung von Alzheimer'scher Demenz |
| DE19906979B4 (de) * | 1999-02-19 | 2004-07-08 | Lts Lohmann Therapie-Systeme Ag | Verwendung von Desoxypeganin zur Behandlung der Nikotinabhängigkeit |
| DE19906974C2 (de) * | 1999-02-19 | 2003-10-09 | Lohmann Therapie Syst Lts | Verwendung von Desoxypeganin zur Behandlung des Alkoholismus |
| DE19906977C1 (de) * | 1999-02-19 | 2000-06-15 | Lohmann Therapie Syst Lts | Desoxypeganin-TTS und seine Verwendung |
| DE19924951B4 (de) * | 1999-05-31 | 2004-02-05 | Lts Lohmann Therapie-Systeme Ag | Verwendung von Desoxypeganin zur Prophylaxe bzw. Vorbehandlung einer Vergiftung durch phosphororganische Cholinesterasehemmer |
| EP1231877A4 (en) * | 1999-11-04 | 2009-03-18 | Xel Herbaceuticals | TRANSDERMALE ADMINISTRATION OF HUPERZIN |
-
2001
- 2001-04-24 DE DE10119863A patent/DE10119863A1/de not_active Withdrawn
-
2002
- 2002-04-18 US US10/475,788 patent/US20040132751A1/en not_active Abandoned
- 2002-04-18 AU AU2002325209A patent/AU2002325209B2/en not_active Ceased
- 2002-04-18 ES ES02758191T patent/ES2316595T3/es not_active Expired - Lifetime
- 2002-04-18 MX MXPA03009766A patent/MXPA03009766A/es active IP Right Grant
- 2002-04-18 SI SI200230779T patent/SI1383503T1/sl unknown
- 2002-04-18 WO PCT/EP2002/004278 patent/WO2002087553A2/de active Application Filing
- 2002-04-18 DK DK02758191T patent/DK1383503T3/da active
- 2002-04-18 HU HU0303921A patent/HUP0303921A3/hu unknown
- 2002-04-18 SK SK1316-2003A patent/SK287214B6/sk not_active IP Right Cessation
- 2002-04-18 CA CA002445132A patent/CA2445132C/en not_active Expired - Fee Related
- 2002-04-18 DE DE50212901T patent/DE50212901D1/de not_active Expired - Lifetime
- 2002-04-18 EP EP02758191A patent/EP1383503B1/de not_active Expired - Lifetime
- 2002-04-18 JP JP2002584899A patent/JP2004526791A/ja active Pending
- 2002-04-18 KR KR10-2003-7013972A patent/KR20030094365A/ko active Search and Examination
- 2002-04-18 IL IL15838302A patent/IL158383A0/xx not_active IP Right Cessation
- 2002-04-18 AT AT02758191T patent/ATE411024T1/de not_active IP Right Cessation
- 2002-04-18 PL PL02366845A patent/PL366845A1/xx not_active IP Right Cessation
- 2002-04-18 CN CNA028088891A patent/CN1638774A/zh active Pending
- 2002-04-18 CZ CZ20032788A patent/CZ20032788A3/cs unknown
- 2002-04-18 EA EA200301134A patent/EA200301134A1/ru unknown
- 2002-04-18 BR BR0209125-9A patent/BR0209125A/pt not_active IP Right Cessation
- 2002-04-18 NZ NZ529005A patent/NZ529005A/en unknown
- 2002-04-18 PT PT02758191T patent/PT1383503E/pt unknown
- 2002-04-22 MY MYPI20021470A patent/MY135676A/en unknown
- 2002-04-24 AR ARP020101483A patent/AR033469A1/es unknown
-
2003
- 2003-10-16 ZA ZA200308042A patent/ZA200308042B/en unknown
- 2003-10-23 NO NO20034741A patent/NO20034741D0/no unknown
-
2004
- 2004-07-05 HK HK04104813.3A patent/HK1062402A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0106717A (pt) | Compostos, composição farmacêutica e usos dos compostos de lactama inovadora | |
| BRPI0414435A (pt) | métodos e reagentes para o tratamento de distúrbios imunoinflamatórios | |
| BR9713186A (pt) | Inibidores de metaloprotease 1,3-diheterocìclicos | |
| PT1485080E (pt) | Utilização de adapaleno para o tratamento de desordens dermatológicas | |
| BR0112093A (pt) | Derivados de sulfonil-pirrolidina úteis no tratamento de distúrbios neurológicos | |
| MX2007008227A (es) | Prevencion de trastornos tromboticos con compuestos de vitamina d activa o mimeticos de los mismos. | |
| WO2005009387A3 (en) | Azepine derivatives as pharmaceutical agents | |
| YU82702A (sh) | Ortosupstituisani amidi antranilne kiseline i njihova primena kao sredstva za lečenje | |
| BR9811093A (pt) | Piridinas substituìdas com 2-amino-6-(4-fenóxi 2-substituìdo) | |
| MA29227B1 (fr) | 4-phenyltetrahydroisoquinoline substituees, leur procedes de fabrication, leur utilisation en tant que medicament et medicament les contenant | |
| BR0316723A (pt) | Derivados de anilinopirazol úteis para o tratamento de diabetes | |
| BRPI0508084A (pt) | método para o tratamento de um distúrbio neurológico, e, uso de meridamicina ou um sal do mesmo | |
| AU6896801A (en) | Use of vegf and homologues to treat neuron disorders | |
| IL169889A0 (en) | Methods for diagnosis and monitoring of neurological disease by detection of an encephalotoxin | |
| CA2132544A1 (en) | Angiotensin ii antagonists against disorders associated with impaired neuronal conduction velocity, especially diabetic neuropathy | |
| EA200301134A1 (ru) | Применение дезоксипеганина для лечения патологических проявлений центральной нервной системы, вызванных интоксикацией психотропными веществами | |
| EA200301135A1 (ru) | Применение галантамина для лечения патологических проявлений центральной нервной системы, вызванных интоксикацией психотропными веществами | |
| NO953892D0 (no) | Imidazolokinoksalinon-derivater som EAA-antagonister | |
| DE602005018179D1 (de) | Behandlung von krankheiten | |
| ES2192874T3 (es) | Proteina c para el tratamiento de la enfermedad de la celula con anemia hepatica y talasemia. | |
| DE60133563D1 (de) | Külen | |
| ATE242766T1 (de) | Neue derivate von benzoylalkyl-1,2,3,6- tetrahydropyridinen | |
| TH88506A (th) | แอนทาโกนิสท์ตัวรับโดพามีน 2 ที่มีการแตกตัวอย่างรวดเร็ว | |
| TH71491A (th) | สารประกอบชนิดใหม่ | |
| TH64264A (th) | เปปไตด์ซึ่งมีคุณสมบัติในการต่อต้านแองจิโอจีนิก |